Forschen für eine Zukunft ohne Diabetes – Deutsches Zentrum für Diabetesforschung

Mit Gründung der Deutschen Zentren der Gesundheitsforschung (DZG) rückt das Bundesministerium für Bildung und Forschung (BMBF) die Volkskrankheiten in den Fokus der medizinischen Wissenschaften. Im Deutschen Zentrum für Diabetesforschung (DZD) arbeiten Grundlagenforscher und Kliniker eng vernetzt an innovativen und individualisierten Präventions- und Therapiestrategien gegen den Diabetes mellitus.

By the establishment of the new networks of six German Centres for Health Research (DZG) the German Federal Ministry of Education and Research aims to create excellent research conditions for combating the most widespread diseases. In the German Center of Diabetes Research (DZD) the best researchers from universities and research institutions work side by side on improved prevention and innovative therapies for patients with an elevated risk or suffering from diabetes mellitus.

Key words

diabetes research - translational research - diabetes prevention - diabetes therapy - DZD

• Literatur

• 1 Hauner H, Koster I, Von Ferber L. Prevalence of diabetes mellitus in Germany 1998–2001. Secondary data analysis of a health insurance sample of the AOK in Hesse/KV in Hesse. Dtsch Med Wochenschr 2003; 128: 2632-2637
• 2 Schulze MB, Rathmann W, Giani G, Joost HG. Diabetesprävalenz – Verlässliche Schätzungen stehen noch aus. Dtsch Arztbl 2010; 107: 1694-1696
• 3 Herder C, Roden M. Genetics of type 2 diabetes: pathophysiologic and clinical relevance. Eur J Clin Invest 2011; 41: 679-692
• 4 Stefan N, Fritsche A, Häring H. Individualisierte Prävention des Typ-2-Diabetes. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2009; 52: 677-682
• 5 Weyrich P, Stefan N, Häring HU, Laakso M, Fritsche A. Effect of genotype on success of lifestyle intervention in subjects at risk for type 2 diabetes. J Mol Med 2007; 85: 107-117
• 6 Stefan N, Haring HU. The metabolically benign and malignant fatty liver. Diabetes 2011; 60: 2011-2017
• 7 Schafer SA, Machicao F, Fritsche A, Haring HU, Kantartzis K. New type 2 diabetes risk genes provide new insights in insulin secretion mechanisms. Diabetes Res Clin Pract (Suppl. 01) 2011; 93: 9-24
• 8 Szendroedi J, Phielix E, Roden M. The role of mitochondria in insulin resistance and type 2 diabetes mellitus. Nat Rev Endocrinol 2012; 8: 92-103
• 9 Boerschmann H, Walter M, Achenbach P, Ziegler AG. Survey of recent clinical trials of the prevention and immunointervention of type 1 diabetes mellitus. Dtsch Med Wochenschr 2010; 135: 350-354
• 10 Joost HG. Pathogenesis, risk assessment and prevention of type 2 diabetes mellitus. Obes Facts 2008; 1: 128-137
• 11 Joost HG. The genetic basis of obesity and type 2 diabetes: lessons from the new zealand obese mouse, a polygenic model of the metabolic syndrome. Results Probl Cell Differ 2010; 52: 1-11
• 12 Fuchs H, Gailus-Durner V, Adler T et al. Mouse phenotyping. Methods 2011; 53: 120-135
• 13 Kullmann S, Heni M, Veit R et al. The obese brain: Association of body mass index and insulin sensitivity with resting state network functional connectivity. Hum Brain Mapp Epub 2011, Apr 2012; 33
• 14 Illig T, Gieger C, Zhai G et al. A genome-wide perspective of genetic variation in human metabolism. Nat Genet 2010; 42: 137-141
• 15 Schloot NC, Roden M, Bornstein SR, Brendel MD. Recent advances in the treatment of type 1 diabetes mellitus. Dtsch Med Wochenschr 2011; 136: 172-175
• 16 Ludwig B, Ziegler CG, Schally AV et al. Agonist of growth hormone-releasing hormone as a potential effector for survival and proliferation of pancreatic islets. PNAS 2010; 107: 12623-12628